True Heal

Semaglutide/B12 Injection for weight loss. HOMEKIT w/ TeleHealth Physicians Consultation

Weight Loss <> May improve Blood Pressure <> May improve cholesterol

Ingredients

Fit Shot Home Kit Includes:

1 month supply of Semaglutide/B12 Combination Injection

(Dosage varies from 0.25mg – 2.4mg and is dependent on the Month ordered)

Syringes

Alcohol Pads

Physician Consultation [online]

Used For

Semaglutide Injection is a once-a-week dose that works by mimicking hormones that target areas of the brain involved in regulating appetite and food intake. This can help you eat less and lead to weight loss.

Our Semaglutide is combined with B12 for energy, sleep cycle regulation and a better patient experience,

Benefits

– Weight Loss

– May improve Blood Pressure

– May improve cholesterol

– Improves Blood Sugar

How to Use

Dosage and Frequency

Once a week

Taken on the same day each week, any time of day, with or without food.

Diet and Exercise

Healthy eating and activity are recommended.

Get the most

out of your Semaglutide/B12 Weight Loss Injection

Looking for more? Try a personalized wellness program for custom infusions, supplement recommendations, expert guidance and monitoring, progress tracking, and comprehensive support.

Start Your Wellness Program Today

IMPORTANT!

THIS PRODUCT FOLLOWS A TITRATION SCHEDULE. ALL PATIENTS MUST START WITH ‘MONTH 1’ DOSE. AFTER MONTH 1, THE DOSAGE PER INJECTION INCREASES GRADUALLY IN MONTH 2, 3, AND 4. LASTLY THE MAINTENAINCE DOSE CAN BE ONGOING FOR UP TO 8 MONTHS DEPENDING ON YOUR GOALS

A MINIMUM BMI OF 27 OR GREATER IS REQUIRED TO ORDER THIS PRODUCT

What is Semaglutide/B12 Weight Loss Injection?

What is Semaglutide?

Semaglutide an incretin mimetic; specifically, semaglutide is a GLP-1 receptor agonist with 94% sequence homology to human GLP-1. Semaglutide binds and activates the GLP-1 receptor. GLP-1 is an important, gut-derived, glucose homeostasis regulator that is released after the oral ingestion of carbohydrates or fats. In patients with Type 2 diabetes, GLP-1 concentrations are decreased in response to an oral glucose load. GLP-1 enhances insulin secretion; it increases glucose-dependent insulin synthesis and in vivo secretion of insulin from pancreatic beta cells in the presence of elevated glucose. In addition to increases in insulin secretion and synthesis, GLP-1 suppresses Glc secretion, slows gastric emptying, reduces food intake, and promotes beta-cell proliferation. The principal mechanism of protraction resulting in the long half-life of semaglutide is albumin binding, which results in decreased renal clearance and protection from metabolic degradation; semaglutide is stabilized against degradation by the DPP-4 enzyme. Semaglutide reduces blood glucose through a mechanism where it stimulates insulin secretion and lowers Glc secretion, both in a glucose-dependent manner. Therefore, when blood glucose is high, insulin secretion is stimulated and Glc secretion is inhibited. The mechanism of blood glucose lowering also involves a minor delay in gastric emptying in the early postprandial phase.